A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

NCT00475735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

DRUG: MK0249
DRUG: Concerta (methylphenidate)
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC